SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,288.77 370.92
( 0.48%)

Global Indices

Nasdaq

51,780.49 -224.49
(-0.43%)

Dow Jones

7,583.75 21.35
(0.28%)

Hang Seng

63,112.86 -177.25
(-0.28%)

Nikkei 225

10,659.07 -102.26
(-0.95%)

Forex

USD-INR

94.80 -0.14
(-0.14%)

EUR-INR

106.11 0.21
(0.20%)

GBP-INR

127.09 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Avience Biomedicals Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

94324

INE0V9I01017

157.0868848

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AVIENCE

20.37

137.13

EPS(TTM)

Face Value()

Div & Yield %

12.27

Back

Fynx Capital reports standalone net loss of Rs 1.98 crore in the June 2026 quarter

Aug 07,2026

Net Loss of Fynx Capital reported to Rs 1.98 crore in the quarter ended June 2026 as against net loss of Rs 0.57 crore during the previous quarter ended June 2025. Sales rose 704.08% to Rs 3.94 crore in the quarter ended June 2026 as against Rs 0.49 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	3.94	0.49	704
OPM %	-28.93	-104.08	-
PBDT	-2.09	-0.51	-310
PBT	-2.15	-0.58	-271
NP	-1.98	-0.57	-247

77,288.77 370.92 ( 0.48%)

51,780.49 -224.49 (-0.43%)

7,583.75 21.35 (0.28%)

63,112.86 -177.25 (-0.28%)

10,659.07 -102.26 (-0.95%)

94.80 -0.14 (-0.14%)

106.11 0.21 (0.20%)

127.09 0.00 (0.00%)

0.60 0.00 (-0.29%)